XBiotech Inc.
XBIT
XBiotech Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing True Human™ monoclonal antibodies for a range of diseases. Its current programs center on therapeutic antibodies derived from naturally occurring human immunity, with a pipeline that targets inflammatory, infectious, and oncology-related conditions. The company’s product development efforts emphasize antibody-based treatments designed to address diseases driven by immune and inflammatory pathways, including areas such as cancer, rheumatology, and infectious disease. XBiotech Inc. also supports the clinical and preclinical advancement of candidate therapies built around its proprietary antibody platform. Headquartered in Austin, Texas, XBiotech Inc. operates as a research-driven company within the biotechnology sector, where it contributes to the development of next-generation biologic medicines for unmet medical needs.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$45M
▼ -18.2% YoY
Op. Margin
–
ROIC
-26.43%
▼ -10.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$41M
▼ -24.6% YoY
Op. Cash Flow (TTM)
-$41M
▼ -28.9% YoY
Net Debt
-$126M
Net Cash Position
Cash & Equiv.
$126M
Continue Research
Peers
Biotechnology · Pick stocks to compare with XBIT
Held by ETFs
XBIT is in 1 US ETF. The largest of them, with XBIT's weight in each:
XBiotech (XBIT) in three numbers
Questions about XBiotech
Is XBiotech a high-quality business?
XBiotech scores 16 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$126M, and its weakest is return on capital at -26.4%. The Quality tab shows every check against its target.
Does XBiotech (XBIT) pay a dividend?
No. XBiotech (XBIT) does not currently pay a dividend. The last payment in our data was in 2021, and nothing has been paid since. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing XBIT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.